Regulating The CGT Workflow To Improve Patient Safety

As regulatory guidelines evolve, and the need to meet accelerated timelines increases, so too does the need for an efficient manufacturing workflow. On August 22, 2023, Cell & Gene's Erin Harris welcomed industry experts Mantej (Nimi) Chhina, Ph.D., J.D., RAC, Executive Director, Head of Global R&D and Regulatory Policy Global Regulatory Affairs Worldwide Research & Development at BioMarin Pharmaceutical Inc., and Robert Pietrusko, Pharm.D., Chief Regulatory & Quality Officer at Vor Biopharma, for a discussion on the latest regulatory developments that impact manufacturing workflow, and therefore, efficacy and patient safety issues.